Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial

Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial

Runhui Wu,1 Jing Sun,2 Weiqun Xu,3 Qun Hu,4 Wenqian Li,5 Jianwen Xiao,6 Feng’e Yang,7 Xiaojing Zeng,8 Yun Zeng,9 Jianfeng Zhou,4 Irina Matytsina,10 Sali Zhang,11 Michael Pluta,12 Renchi Yang13 1Hematology Oncology Center, Beijing Children’s Hospital, Capital Medical University, N...

Full description

Saved in:
Bibliographic Details
Main Authors: Wu R, Sun J, Xu W, Hu Q, Li W, Xiao J, Yang F, Zeng X, Zeng Y, Zhou J, Matytsina I, Zhang S, Pluta M, Yang R
Format: article
Language:EN
Published: Dove Medical Press 2020
Subjects:
hemophilia a
prophylaxis
recombinant factor viii
turoctocog alfa
china
Therapeutics. Pharmacology
RM1-950
Online Access:https://doaj.org/article/8f16c00516164c3a87a7fd931c2b8412
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/8f16c00516164c3a87a7fd931c2b8412

Similar Items